Ireland


Welcome to AstraZeneca in Ireland

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, Vaccines & Immune Therapies and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca is present in over 100 countries1 and its innovative medicines are used by millions2 of patients worldwide.

At AstraZeneca in Ireland, we aim to stimulate continued creativity throughout our organisation by maintaining a culture in which our people feel valued, energised and rewarded for their ideas and contribution to our success – which can make a difference in all aspects of our business and to healthcare in Ireland.

Currently more than 100 people are employed by AstraZeneca in Ireland with a wide range of expertise in different areas including sales, marketing, medical, regulatory affairs, market access, corporate affairs, patient safety, medical information, IT, digital, finance and administration. 

In 2021 AstraZeneca invested $360 million3 to establish a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules in Dublin. We expect this investment programme to significantly reduce commercialisation lead times and costs, and introduce more sustainable manufacturing processes, contributing to our Ambition Zero Carbon programme.

Worldwide, AstraZeneca invested over $10.9 billion4 in 2023 on research and development highlighting our dedication to finding new medicines that make a real difference to patients’ lives.

Please visit 517b2b.com and follow the Company on social media @AstraZeneca

Primary Contact

AstraZeneca Pharmaceuticals (Ireland) DAC
College Business and Technology Park, Blanchardstown Road North,Dublin 15, D15 R925


Tel: 01-6097100 
Fax: 01-6865038




Our global focus areas



Our medicines


Summary of Product Characteristics (SPCs)

For information on AstraZeneca Ireland’s products please click on the relevant Summary of Product Characteristic link in the IPHA electronic compendium.

If you have a further query on any AstraZeneca product please contact us or phone 01-6097100.

In Ireland, AstraZeneca's focus is in following therapy areas: Cardiovascular and Metabolic diseases, Oncology and Respiratory.




Patient Group Support


At AstraZeneca Ireland, our commitment to patients drives everything we do. Our mission is to pioneer groundbreaking science to create life-changing medicines that improve patient outcomes. We work hand in hand with the scientific community to discover and develop innovative treatments, and we collaborate closely with healthcare organisations and patient groups to advance patient health.

As part of our dedication to supporting patients, we provide charitable donations and sponsorships to organisations that drive healthcare innovations, raise disease awareness, promote health literacy, and empower patients to take control of their health journey.

In our commitment to transparency, we provide a summary of our contributions to patient organizations. You can access this information through the links below.





Work for us


Interested in joining us?

We turn good ideas into effective medicines that make a real difference for patients around the world. Good ideas depend on good people and we want to recruit the best.

We aim to give our people the right combination of freedom and support so that they can develop their potential to the full and channel their energy to effectively meet the challenges of working as part of a global business.

Job vacancies occur from time to time in areas such as Sales, Marketing, Market access, Medical & Regulatory Affairs, Medical information, Pharmacovigilance and Administration. If you are interested in joining AstraZeneca Pharmaceuticals (Ireland) DAC, please contact us sending a copy of your latest CV.

Important notice

Potential candidates should be wary of approaches that appear to be offering a job for which they have not applied, especially if personal details or money must be sent in order to proceed with the recruitment. Neither AstraZeneca nor any commissioned third parties recruit in this manner. Such approaches are almost certainly fraudulent attempts to gain details of identity for illegal use.



Contact Details


AstraZeneca is ranked as one of the world’s leading pharmaceutical companies. In Ireland, AstraZeneca Pharmaceuticals (Ireland) DAC. is primarily a Sales, Medical Affairs & Marketing Company centered in College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925

Our Address

AstraZeneca Pharmaceuticals (Ireland) DAC, College Business and Technology Park, Blanchardstown Road North,Dublin 15, D15 R925  Phone 01-6097100

Travel Time from Dublin City Center is approximately 30 to 40 minutes.




AstraZeneca Pharmaceuticals (Ireland) DAC - Standard Terms and Conditions for the Purchase of Goods and Services


Reporting Adverse Events

Any drug may produce unwanted adverse events. Adverse Events should be reported. Reporting forms and information can be found at www.hpra.ie. All adverse events should also be reported to AstraZeneca via http://www.contactazmedical.517b2b.com or by freephone 1800800899“

 


References:

1. AstraZeneca Annual Report & Form 20-F Information 2023, page 10 [http://mys5.517b2b.com/investor-relations/annual-reports/annual-report-2023.html]

2. AstraZeneca Annual Report & Form 20-F Information 2023, page 10 [http://mys5.517b2b.com/investor-relations/annual-reports/annual-report-2023.html]

3. AstraZeneca to invest $360m in advanced manufacturing facility in Ireland [http://mys5.517b2b.com/media-centre/press-releases/2021/astrazeneca-360m-irish-manufacturing-investment.html#]

4. AstraZeneca Annual Report & Form 20-F Information 2023, page 34 [http://mys5.517b2b.com/investor-relations/annual-reports/annual-report-2023.html]

 


What science can do

Science compels us to push the boundaries of what is possible. We trust in the potential of ideas and pursue them, alone and with others, until we have transformed the treatment of disease.